Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-04

Clinical Trial Update: Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for dexlansoprazole in Asian patients with gastroesophageal reflux disease completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXLANSOPRAZOLE (DEXLANSOPRAZOLE)

Snippet

Sponsor: Takeda | Conditions: Gastroesophageal Reflux Disease | Phase 4 | Status: COMPLETED | Results posted: 2017-10-04